03/06/2017 - 4:46pm

Among the 22 novel new drugs approved by the Food and Drug Administration in 2016, about half were considered specialty drugs.

03/03/2017 - 12:35pm

The bill would establish a national age-18 requirement for the purchase of the medicines containing DXM. Over the past several years,12 states have addressed this issue by passing similar legislation.

03/03/2017 - 11:46am

The bill will create more accountability for how federal health programs deliver prescription drug services, NCPA noted.

02/28/2017 - 5:46pm

More than 200 members of Americans for Affordable Products stated in a letter to politicians that the BAT is tantamount to “a ‘cost of living tax’ that will make the lives of millions of middle-class Americans harder and more expensive.”

02/28/2017 - 1:25pm

The letter reaffirmed NCPA's support of President Trump's initiatives to reduce prescription drug costs and enhance transparency.

02/27/2017 - 4:38pm

During his listening session with representatives from the health insurance industry about the proposed repeal of the Affordable Care Act, President Trump said, “we're going to come up with something where not only will the market be great, but the people are going to be taken care of.” 

02/27/2017 - 3:07pm

The new by-laws were approved by the full membership on Feb. 17, 2017. 

02/24/2017 - 1:40pm

Approximately 530 Alabama independent drug store owners are seeking relief of as much as $5,000 per store per year in business license fees by excluding prescription sales from gross receipts, according to a report published Friday by the Alabama Media Group. State legislation has been introduced to that end, but is opposed by local municipalities looking at stark revenue reductions. "Cities like Montgomery and Mobile claim the hit would be excessive," the report noted. "In Mobile, city officials estimate that computing a store's gross sales by including prescription medicine has brought in an average of $465,000 annually for the past five years." (AL.com)

02/24/2017 - 10:36am

Panelists offered perspectives on efforts currently underway to move the healthcare system toward one that rewards innovation, delivers better quality and puts the patient at the center of the value equation.